Table of Contents

1 Market Overview
1.1 Drugs for Herpes Labialis (Oral Herpes) Introduction
1.2 Market Analysis by Type
1.2.1 Aciclovir
1.2.2 Valacyclovir
1.2.3 Famciclovir
1.2.4 Docosanol
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 External Use
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva
2.3.1 Business Overview
2.3.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Cadila
2.5.1 Business Overview
2.5.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Apotex
2.6.1 Business Overview
2.6.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Daewoong Pharmaceutical
2.7.1 Business Overview
2.7.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Livzon
2.8.1 Business Overview
2.8.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Luoxin
2.9.1 Business Overview
2.9.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Med shine
2.10.1 Business Overview
2.10.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bayer (Campho Phenique)
2.11.1 Business Overview
2.11.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Blistex
2.12.1 Business Overview
2.12.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Kelun Group
2.13.1 Business Overview
2.13.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Hikma
2.14.1 Business Overview
2.14.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Haiwang
2.15.1 Business Overview
2.15.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Carmex
2.16.1 Business Overview
2.16.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Cipher
2.17.1 Business Overview
2.17.2 Drugs for Herpes Labialis (Oral Herpes) Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drugs for Herpes Labialis (Oral Herpes) Market Competition, by Manufacturer
3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Market Share by Manufacturer
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Herpes Labialis (Oral Herpes) Manufacturer Market Share
3.3.2 Top 6 Drugs for Herpes Labialis (Oral Herpes) Manufacturer Market Share
3.4 Market Competition Trend
4 Global Drugs for Herpes Labialis (Oral Herpes) Market Analysis by Regions
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions (2012-2017)
4.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions (2012-2017)
4.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
4.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
4.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
4.5 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
4.6 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
5 North America Drugs for Herpes Labialis (Oral Herpes) by Countries
5.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2012-2017)
5.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2012-2017)
5.2 USA Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
5.3 Canada Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
5.4 Mexico Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
6 Europe Drugs for Herpes Labialis (Oral Herpes) by Countries
6.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2012-2017)
6.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2012-2017)
6.2 Germany Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
6.3 UK Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
6.4 France Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
6.5 Russia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
6.6 Italy Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
7 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) by Countries
7.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2012-2017)
7.2 China Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
7.3 Japan Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
7.4 Korea Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
7.5 India Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
7.6 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
8 South America Drugs for Herpes Labialis (Oral Herpes) by Countries
8.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2012-2017)
8.1.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2012-2017)
8.2 Brazil Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
8.3 Argentina Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
8.4 Columbia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
9 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) by Countries
9.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2012-2017)
9.2 Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
9.3 UAE Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
9.4 Egypt Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
9.5 Nigeria Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
9.6 South Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth (2012-2017)
10 Global Drugs for Herpes Labialis (Oral Herpes) Market Segment by Type
10.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Market Share by Type (2012-2017)
10.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type (2012-2017)
10.2 Aciclovir Sales Growth and Price
10.2.1 Global Aciclovir Sales Growth (2012-2017)
10.2.2 Global Aciclovir Price (2012-2017)
10.3 Valacyclovir Sales Growth and Price
10.3.1 Global Valacyclovir Sales Growth (2012-2017)
10.3.2 Global Valacyclovir Price (2012-2017)
10.4 Famciclovir Sales Growth and Price
10.4.1 Global Famciclovir Sales Growth (2012-2017)
10.4.2 Global Famciclovir Price (2012-2017)
10.5 Docosanol Sales Growth and Price
10.5.1 Global Docosanol Sales Growth (2012-2017)
10.5.2 Global Docosanol Price (2012-2017)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2012-2017)
10.6.2 Global Other Price (2012-2017)
11 Global Drugs for Herpes Labialis (Oral Herpes) Market Segment by Application
11.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2012-2017)
11.2 External Use Sales Growth (2012-2017)
11.3 Oral Sales Growth (2012-2017)
11.4 Injection Sales Growth (2012-2017)
12 Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
12.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2017-2022)
12.2 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Regions (2017-2022)
12.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
12.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
12.2.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
12.2.4 South America Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
12.2.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2017-2022)
12.3 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Type (2017-2022)
12.4 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source